These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 683623)

  • 41. Human placental lactogen and ultrasonic screening for the detection of placental insufficiency.
    Kullander S; Marsál K; Persson PH
    Contrib Gynecol Obstet; 1982; 9():129-44. PubMed ID: 6754247
    [No Abstract]   [Full Text] [Related]  

  • 42. The diagnostic significance of hCG and hPL via immunohistochemistry of placental tissues in pregnancies diagnosed with IUGR and IUD.
    Günyeli I; Zergeroğlu S; Danişman N; Mollamahmutoğlu L
    J Obstet Gynaecol; 2009 Aug; 29(6):521-5. PubMed ID: 19697201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ultrasonic, hormonal and biochemical study of intrauterine fetal development in healthy and sick women].
    Fuchs V; Kotásek A
    Cesk Pediatr; 1981 Aug; 36(8):438-43. PubMed ID: 7273225
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum levels of oestriol and human placental lactogen.
    Llewellyn-Jones JD
    Med J Aust; 1979 Dec; 2(13):700-1. PubMed ID: 530205
    [No Abstract]   [Full Text] [Related]  

  • 45. [Surveillance of pregnancies with placental dysfunction. V. Time of the appearance of suspected and pathological values during surveillance methods].
    Schmid J; Baertschi U
    Z Geburtshilfe Perinatol; 1976 Feb; 180(1):25-60. PubMed ID: 1266272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal blood levels of human placental lactogen in the prediction of fetal growth retardation: choosing a cut-off point between normal and abnormal.
    Lilford RJ; Obiekwe BC; Chard T
    Br J Obstet Gynaecol; 1983 Jun; 90(6):511-5. PubMed ID: 6860597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Placental perfusion, endocrine parameters of pregnancy and cardiotocographic non-stress tests in cases of intrauterine retardation].
    Doszpod J; Török M; Prievara F; Csákány MG; Gáti I
    Zentralbl Gynakol; 1984; 106(21):1413-8. PubMed ID: 6516633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human placental lactogen and intrauterine growth retardation.
    Spellacy WN; Buhi WC; Birk SA
    Obstet Gynecol; 1976 Apr; 47(4):446-8. PubMed ID: 1256729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [HPL serum levels in intrauterine retardation of fetal growth during late pregnancy (author's transl)].
    Siebert W; Meitinger C; Vogt W; Sandel P
    Geburtshilfe Frauenheilkd; 1974 Jul; 34(7):520-4. PubMed ID: 4848903
    [No Abstract]   [Full Text] [Related]  

  • 50. The efficacy of biochemical assays in assessing an IUGR risk-group, preselected with ultrasound fetometry.
    Laurin J; Persson PH; Fernlund P
    Eur J Obstet Gynecol Reprod Biol; 1987 Mar; 24(3):177-87. PubMed ID: 2951284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relationship between the biparietal diameter of the fetal head, human placental lactogen (HPL), thermostable alkaline phosphatase, and blood oxytocinase in risk pregnancy].
    Lukacín S; Sedlák J; Rod J; Strozová A; Jurcová E; Fialová B
    Bratisl Lek Listy; 1981 Feb; 75(2):179-84. PubMed ID: 7214183
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R; Marinov B; Milkov V; Milanov S
    Akush Ginekol (Sofiia); 1984; 23(4):315-20. PubMed ID: 6207743
    [No Abstract]   [Full Text] [Related]  

  • 53. The relative significance of human placental lactogen in the diagnosis of retarded fetal growth.
    Daikoku NH; Tyson JE; Graf C; Scott R; Smith B; Johnson JW; King TM
    Am J Obstet Gynecol; 1979 Oct; 135(4):516-21. PubMed ID: 484651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal diagnosis and treatment of intrauterine growth retardation.
    Kaneoka T; Taguchi S; Shimizu H; Shirakawa K
    J Perinat Med; 1983; 11(4):204-12. PubMed ID: 6620103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Human placentar lactogen (HPL) in the serum. Its diagnostic value in intra-uterine retardation of growth].
    Bellmann O; Lang N
    Z Geburtshilfe Perinatol; 1973 Apr; 177(2):97-109. PubMed ID: 4718770
    [No Abstract]   [Full Text] [Related]  

  • 56. The value of serum cystine aminopeptidase (CAP), human chorionic somato-mammotrophin (HCS), and urinary oestrogen assays for detecting intrauterine growth retardation.
    Rydén G
    Acta Obstet Gynecol Scand; 1978; 57(3):211-5. PubMed ID: 665162
    [No Abstract]   [Full Text] [Related]  

  • 57. Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation.
    Westergaard JG; Teisner B; Hau J; Grudzinskas JG
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1216-23. PubMed ID: 6083800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical significance of human placental lactogen analysis in endocrine tests of the gonadal and placental system].
    Mochizuki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():1286-92. PubMed ID: 2695667
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prognostic potentials of certain parameters in fetal growth retardation].
    Ruseva R; Marinov B
    Akush Ginekol (Sofiia); 1983; 22(5):367-72. PubMed ID: 6675477
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hormonal diagnosis in fetal intrauterine retardation].
    Benz J; Ingold W; Landolt A; Keller PJ
    Gynakol Rundsch; 1980 Jun; 20 Suppl 1():74-6. PubMed ID: 6971241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.